Stock listing

MGX Stock Price, News, Filings & Events — Metagenomi Therapeutics, Inc.

Selected listing: MGX · NASDAQ · USD · US

This page tracks Metagenomi Therapeutics, Inc.'s MGX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MGX:NASDAQ. MGX:NASDAQ is the stock-level entry point for investors researching Metagenomi Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Metagenomi Therapeutics, Inc. is a public company traded under the ticker MGX in the American market. The company has a market capitalization of approximately $45.36 million. Metagenomi focuses on developing innovative gene editing technologies to advance therapeutic solutions.